Autologous Cord Blood Therapy for Infantile Cerebral Palsy: From Bench to Bedside
About 17 million people worldwide live with cerebral palsy, the most common disability in childhood, with hypoxic-ischemic encephalopathy, preterm birth, and low birth weight being the most important risk factors. This review will focus on recent developments in cell therapy for infantile cerebral p...
Saved in:
Main Author: | A. Jensen |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2014-01-01
|
Series: | Obstetrics and Gynecology International |
Online Access: | http://dx.doi.org/10.1155/2014/976321 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
First Autologous Cord Blood Therapy for Pediatric Ischemic Stroke and Cerebral Palsy Caused by Cephalic Molding during Birth: Individual Treatment with Mononuclear Cells
by: A. Jensen, et al.
Published: (2016-01-01) -
First Autologous Cell Therapy of Cerebral Palsy Caused by Hypoxic-Ischemic Brain Damage in a Child after Cardiac
Arrest—Individual Treatment with Cord Blood
by: A. Jensen, et al.
Published: (2013-01-01) -
Nutrition: From Bench to Bedside
by: Naim A. Khan, et al.
Published: (2016-01-01) -
Helicobacter pylori: From Bench to Bedside
by: N Chiba, et al.
Published: (1997-01-01) -
Bench to Bedside : diagnostic microbiology for the clinicians /
Published: (2018)